Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study

Introduction Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder that results in functional deficits. However, these functional declines are often not able to be quantified in clinical trials for DMD until after age 7. In this study, we hypothesized that 1H2O T2 derived using 1H-MRS and MRI-T2 will be sensitive to muscle involvement at a young age (5–7 years) consistent with increased inflammation and muscle damage in a large cohort of DMD subjects compared to controls. Methods MR data were acquired from 123 boys with DMD (ages 5–14 years; mean 8.6 SD 2.2 years) and 31 healthy controls (age 9.7 SD 2.3 years) using 3-Tesla MRI instruments at three institutions (University of Florida, Oregon Health & Science University, and Children’s Hospital of Philadelphia). T2-weighted multi-slice spin echo (SE) axial images and single voxel 1H-MRS were acquired from the lower leg and thigh to measure lipid fraction and 1H2O T2. Results MRI-T2, 1H2O T2, and lipid fraction were greater (p<0.05) in DMD compared to controls. In the youngest age group, DMD values were different (p<0.05) than controls for the soleus MRI-T2, 1H2O T2 and lipid fraction and vastus lateralis MRI-T2 and 1H2O T2. In the boys with DMD, MRI-T2 and lipid fraction were greater (p<0.05) in the oldest age group (11–14 years) than the youngest age group (5–6.9 years), while 1H2O T2 was lower in the oldest age group compared to the young age group. Discussion Overall, MR measures of T2 and lipid fraction revealed differences between DMD and Controls. Furthermore, MRI-T2 was greater in the older age group compared to the young age group, which was associated with higher lipid fractions. Overall, MR measures of T2 and lipid fraction show excellent sensitivity to DMD disease pathologies and potential therapeutic interventions in DMD, even in the younger boys.

[1]  P. Carlier,et al.  Validation of a generic approach to muscle water T2 determination at 3T in fat‐infiltrated skeletal muscle , 2015, Journal of magnetic resonance imaging : JMRI.

[2]  R. Finkel,et al.  Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS , 2014, Neurology.

[3]  Krista Vandenborne,et al.  Chemical shift‐based MRI to measure fat fractions in dystrophic skeletal muscle , 2014, Magnetic resonance in medicine.

[4]  C. Senesac,et al.  Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy , 2014, Neuromuscular Disorders.

[5]  M. Versluis,et al.  Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy , 2014, Neuromuscular Disorders.

[6]  P. Carlier.  Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: Different methodology, different information and different implications , 2014, Neuromuscular Disorders.

[7]  Daniel G. Miller,et al.  Longitudinal features of stir bright signal in FSHD1 , 2014, Muscle & nerve.

[8]  Eric P Hoffman,et al.  Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. , 2013, Discovery medicine.

[9]  A. Mayhew,et al.  Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy , 2013, Developmental medicine and child neurology.

[10]  R. Finkel,et al.  Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. , 2013, Radiology.

[11]  Jasper M. Morrow,et al.  Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study , 2013, PloS one.

[12]  J. Miller,et al.  Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network , 2013, Neuromuscular Disorders.

[13]  S. Daack-Hirsch,et al.  Parental perspectives on the diagnostic process for Duchenne and Becker muscular dystrophy , 2013, American journal of medical genetics. Part A.

[14]  W. Triplett,et al.  T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross‐sectional study of lower leg muscles in 5–15‐year‐old boys with Duchenne muscular dystrophy , 2013, NMR in biomedicine.

[15]  R. Finkel,et al.  MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy , 2012, Neuromuscular Disorders.

[16]  W. Semmler,et al.  Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration , 2012, Journal of Neurology.

[17]  S. Friedman,et al.  The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy , 2012, Muscle & nerve.

[18]  B. Tseng,et al.  Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study , 2012, Skeletal Radiology.

[19]  Jay J. Han,et al.  Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences , 2012, PLoS currents.

[20]  S. Pandya,et al.  Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy , 2011, Genetics in Medicine.

[21]  S. Forbes,et al.  Changes in muscle T2 and tissue damage after downhill running in mdx Mice , 2011, Muscle and Nerve.

[22]  Raffaele Iorio,et al.  CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI , 2011, Journal of Clinical Immunology.

[23]  Oliver Bieri,et al.  Quantification of fat infiltration in oculopharyngeal muscular dystrophy: Comparison of three MR imaging methods , 2011, Journal of magnetic resonance imaging : JMRI.

[24]  Marika Pane,et al.  North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy , 2010, Neuromuscular Disorders.

[25]  R. Finkel,et al.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management , 2010, The Lancet Neurology.

[26]  I. Graham,et al.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study , 2009, The Lancet Neurology.

[27]  M. Main,et al.  M.P.2.01 Reliability of the north star ambulatory assessment in a multicentric setting , 2009, Neuromuscular Disorders.

[28]  M. Main,et al.  Reliability of the North Star Ambulatory Assessment in a multicentric setting , 2009, Neuromuscular Disorders.

[29]  D. Thedens,et al.  Sarcolemma-localized nNOS is required to maintain activity after mild exercise , 2008, Nature.

[30]  Meenal Patel,et al.  PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.

[31]  Mehmet Bilgen,et al.  Characterization of Alterations in Diabetic Myocardial Tissue Using High Resolution MRI , 2006, The International Journal of Cardiovascular Imaging.

[32]  A. Connolly,et al.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.

[33]  Graham Wright,et al.  Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. , 2004, AJR. American journal of roentgenology.

[34]  E. Moser,et al.  1H NMR relaxation times of skeletal muscle metabolites at 3 T , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[35]  H. Potter,et al.  T2 quantitation of articular cartilage at 1.5 T , 2003, Journal of magnetic resonance imaging : JMRI.

[36]  B. Petrof.  Molecular Pathophysiology of Myofiber Injury in Deficiencies of the Dystrophin-Glycoprotein Complex , 2002, American journal of physical medicine & rehabilitation.

[37]  Dongsheng Duan,et al.  Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy , 2002, Nature Medicine.

[38]  J. Schotland,et al.  Spectral quantitation by principal component analysis using complex singular value decomposition , 1999, Magnetic resonance in medicine.

[39]  J. Pivarnik,et al.  MR measurements of muscle damage and adaptation after eccentric exercise. , 1998, Journal of applied physiology.

[40]  J. Frahm,et al.  Localized Proton NMR spectroscopy using stimulated echoes: Applications to human skeletal muscle in vivo , 1991, Magnetic resonance in medicine.

[41]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[42]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[43]  J. G. Jeffreys.  The Alfianello Meteorite , 1883, Nature.

[44]  Steven C.R. Williams,et al.  Proc. Intl. Soc. Mag. Reson. Med. , 2012 .

[45]  Vicente Gilsanz,et al.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. , 2008, AJR. American journal of roentgenology.